首页> 外文期刊>SAHARA-J >Equity in access to ARV drugs in Malawi
【24h】

Equity in access to ARV drugs in Malawi

机译:马拉维获得抗逆转录病毒药物的公平性

获取原文
       

摘要

This paper discusses the issue of equity in the distribution of ARV drugs in the Malawi health system. Malawi is one of the countries most severely affected by HIV/AIDS in southern Africa. It is also one of the poorest countries in the world. ARV drugs are expensive. The Malawi government, with assistance from the Global Fund on Tuberculosis, Malaria and HIV/AIDS, started providing free ARV drugs to eligible HIV-infected people in September 2004. The provision of free drugs brought the hope that everyone who was eligible would access them. Based on data collected through a qualitative research methodology, it was found that achieving equity in provision would face several challenges including policy, operational and socio-economic considerations. Specifically, the existing policy framework, shortage of medical personnel, access to information and inadequacy of effective community support groups are some of the key issues affecting equity.
机译:本文讨论了马拉维卫生系统中抗逆转录病毒药物分配中的公平问题。马拉维是南部非洲受艾滋病毒/艾滋病影响最严重的国家之一。它也是世界上最贫穷的国家之一。抗逆转录病毒药物昂贵。马拉维政府在结核病,疟疾和艾滋病毒/艾滋病全球基金的协助下,于2004年9月开始向符合条件的艾滋病毒感染者免费提供抗逆转录病毒药物。免费药物的提供带来了希望,所有符合条件的人都可以使用它们。根据通过定性研究方法收集的数据,发现实现公平分配将面临若干挑战,包括政策,业务和社会经济方面的考虑。具体而言,现有政策框架,医务人员短缺,信息获取以及有效的社区支持团体不足是影响公平的一些关键问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号